FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
31
FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

FIT Biotech Oy

Company release October 6, 2017 at 10:00 AM EET

Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the FIT Biotech Oy ("Company") and Bracknor Investment ("Bracknor") the Company's board of directors have  resolved on October 5, 2017 to approve Bracknor's request relating to the funding programme to convert EUR 40,000 worth of Convertible Capital Notes into the Company's K shares.

Due to the conversion of the Convertible Capital Notes, the Company issues 1,371,977 new K shares in the Company to Bracknor with the conversion price of EUR 0.029155 per share.

As a result of the issue of the new K shares in the Company, the total number of shares in the Company will increase to 78,261,621 shares, and the share capital of the Company will be increased by EUR 39,999.99. After the issue of the new K shares in the Company, the Company's shares will be divided in share series as follows: 78,191,157 K shares, 5,229 A shares and 65,235 D shares.

The increase of the share capital and new K shares in the Company will be registered in the Trade Register on or about October 9, 2017 and the new K shares will be admitted to trading on First North Finland on or about October 10, 2017.

FIT BIOTECH OY

Board of Directors

For further information: Chairman of the Board of Directors Rabbe Slätis E-mail: rabbe.slatis@fitbiotech.com

Certified Advisor: Aalto Capital Partners Oy, tel. +358 40 587 7000

About FIT Biotech FIT Biotech Oy is a biotechnology company established in 1995. The company develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland marketplace maintained by Nasdaq Helsinki Oy.

DISTRIBUTION: NASDAQ OMX Helsinki Principal media

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HIZENERGY Sustains Tier 1 Status Amid Tighter Criteria

Updated Category News Views 30

Another Feather in HIZENERGY's Cap In a landscape where credibility can make or break a business, HIZENERGY has once again staked its claim as a powerhouse. Come Q4 2026, and despite a rougher sea to navigate with BloombergNEF’s (BNEF) upgraded Tier 1 criteria, the company held its own. For those unacquainted, securing a place on this lofty list involves some serious...

Continue Reading
EASE Unlocks $9.5M for AI Medical Expansion in Africa

Updated Category News Views 8

Transforming Healthcare in South Africa and Ghana Expanding into uncharted territories often requires a leap of faith, and EASE Holdings has just taken a substantial one. The medical equipment-as-a-service provider has grabbed a hefty $9.5 million in equity from AAFC Group Inc. The goal? To flood South Africa and Ghana with cutting-edge medical imaging and surgical...

Continue Reading
Brigham Nurses Dig In for Strike: Fight for Fairness

Updated Category News Views 118

Strike Looms as Brigham Nurses Demand Fair Treatment Massachusetts is gearing up for its largest open-ended nursing strike in history as Brigham and Women's Hospital nurses prepare to lay down their tools in pursuit of a just contract. This ain't your typical workplace squabble; it's a full-blown battle for patient safety and professional respect. The Core Grievances at...

Continue Reading
Ascletis Showcases Bold Moves in Obesity Drug Arena

Updated Category News Views 0

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Continue Reading
Sinopec Unveils Biodiversity Report at COP17

Updated Category News Views 6

Sinopec's First Step on the Global Biodiversity Stage Seems like Sinopec (HKG: 0386) has decided to toss its hat into the biodiversity conservation ring. At COP17 in Armenia, they released their inaugural Global Biodiversity Conservation Report—an event that marks more than just a company selling oil and gas. Now, they're talking wildlife and ecologies. Is that irony,...

Continue Reading
Dutch Bros Pours Holiday Cheer with New Festive Menu

Updated Category News Views 201

New Festive Offerings from Dutch Bros Kicking off the holiday season with a splash of vibrant flavors, Dutch Bros is shaking up the menu with some fresh, festive entries. Two new drink concoctions hit the stage alongside a themed delectable treat, and for those traditionalists, perennial favorites make a triumphant return. Dutch Bros Expands Its Vibrant Lineup It's not...

Continue Reading
Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Updated Category News Views 285

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Continue Reading
Afghanistan Claims Hong Kong Sixes in Thrilling Run Chase

Updated Category News Views 216

Afghanistan's Dazzling Triumph Brace ourselves, because what just unfolded in the Hong Kong Sixes 2026 is nothing short of spectacular. Afghanistan's cricket team penned a brand-new chapter in the game's history by overcoming Australia in a pulsating final to capture their maiden Hong Kong Sixes title. Imagine this: chasing a formidable target of 116, they wrapped up the...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 245

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Updated Category News Views 196

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Recent Market Trends for Royal Caribbean Group

Updated Category News Views 162

Understanding Recent Whale Activity in RCL Options In the realm of stock trading, certain investors, often referred to as ‘whales’, have shown a significant bullish inclination towards Royal Caribbean Group. These investors, known for their large financial capabilities, have made notable trades that could signal underlying market confidence in RCL. Analyzing Trade...

Continue Reading
Tecnoglass Declares Quarterly Dividend for Shareholders

Updated Category News Views 43

Tecnoglass Declares Dividend for Shareholders Miami, FL – Tecnoglass, Inc. (NYSE: TGLS) has announced a quarterly dividend of $0.11 per share. This decision underscores the company's commitment to delivering value to its shareholders, resulting in a total of $0.44 on an annual basis. Shareholders who are on record as of September 30, 2024, will receive their dividends...

Continue Reading
Exploring AI-Powered Robots in Firefighting for Tomorrow

Updated Category News Views 348

Potential of AI Robots in Wildfire Management As wildfires rage across various regions, the technology sector is turning its attention to innovative solutions. One such solution comes from Nvidia, a frontrunner in artificial intelligence (AI) research. Nvidia researcher Jim Fan has been vocal about the incredible potential AI-powered robots could have in combating...

Continue Reading
Genelux Corporation's Innovative Immunotherapy Advances in 2025

Updated Category News Views 156

Genelux Corporation's Upcoming Insights at a Prominent Healthcare Event Genelux Corporation, a pioneering name in the field of immuno-oncology, is gearing up for an insightful fireside chat at the Piper Sandler 37th Annual Healthcare Conference. This event is set to occur in early December, and key executives from the company will share their vision and updates....

Continue Reading
Reins Revolutionizes Equity Sharing for Contracting Businesses

Updated Category News Views 117

Reins Celebrates Major Milestone in Alternative Equity Solutions Reins, a leading innovator in alternative equity solutions for privately owned businesses, has recently marked a significant achievement. The firm proudly announces that over $25 million has been distributed in alternative equity across its client base in a remarkable year of growth and success. Transforming...

Continue Reading